Skip to main
AMN
AMN logo

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 29%
Sell 14%
Strong Sell 0%

Bulls say

AMN Healthcare Services Inc reported second-quarter results with revenue of $658.2 million, which, despite a year-over-year decline of 11%, surpassed both the company’s and consensus estimates. The gross margin increased to 29.8%, exceeding the upper end of the company’s guidance range, and represents a sequential improvement of 120 basis points. Furthermore, the company has demonstrated a consistent track record of exceeding revenue and EBITDA estimates, with average surprises of +3% and +12%, respectively, contributing to a positive outlook for the stock.

Bears say

AMN Healthcare Services Inc reported a decline of 9% year-over-year in segment revenue for its nurse and allied solutions, despite exceeding estimates, while the gross margin also saw a slight decrease of 40 basis points sequentially. The company's overall segment revenue for this category dropped 14% year-over-year, reflecting challenges with average travelers on assignment down 3% quarter-over-quarter, and significant weaknesses in its vendor management system (VMS) revenue, which plummeted by 31% year-over-year. Additionally, while segment operating margin experienced a minor drop of 30 basis points quarter-over-quarter, it remains concerning that overall demand within the healthcare staffing sector appears to be weakening, amidst mixed performance across different revenue streams.

AMN has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 7 analysts, AMN has a Buy consensus rating as of Oct 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.